Sinocare Inc (SHE:300298) — Market Cap & Net Worth
Market Cap & Net Worth: Sinocare Inc (300298)
Sinocare Inc (SHE:300298) has a market capitalization of $1.28 Billion (CN¥8.76 Billion) as of September 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #7876 globally and #1788 in its home market, demonstrating a 0.97% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sinocare Inc's stock price CN¥15.63 by its total outstanding shares 560267306 (560.27 Million). Also see Sinocare Inc balance sheet assets for a full breakdown of the balance sheet.
Sinocare Inc Market Cap History: 2015 to 2026
Sinocare Inc's market capitalization history from 2015 to 2026. Data shows change from $1.40 Billion to $1.28 Billion (-0.25% CAGR). Also see Sinocare Inc operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Sinocare Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sinocare Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Sinocare Inc (300298) stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.48x
Sinocare Inc's market cap is 0.48 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.49x
Sinocare Inc's market cap is 6.49 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.40 Billion | $645.50 Million | $143.66 Million | 2.18x | 9.78x |
| 2016 | $934.44 Million | $795.84 Million | $115.20 Million | 1.17x | 8.11x |
| 2017 | $1.25 Billion | $1.03 Billion | $257.97 Million | 1.21x | 4.85x |
| 2018 | $811.39 Million | $1.55 Billion | $310.45 Million | 0.52x | 2.61x |
| 2019 | $1.17 Billion | $1.78 Billion | $250.68 Million | 0.66x | 4.68x |
| 2020 | $2.84 Billion | $2.02 Billion | $186.89 Million | 1.41x | 15.20x |
| 2021 | $2.39 Billion | $2.36 Billion | $107.57 Million | 1.01x | 22.21x |
| 2022 | $2.73 Billion | $3.95 Billion | $446.51 Million | 0.69x | 6.11x |
| 2023 | $2.47 Billion | $4.06 Billion | $284.40 Million | 0.61x | 8.70x |
| 2024 | $2.12 Billion | $4.44 Billion | $326.29 Million | 0.48x | 6.49x |
Competitor Companies of 300298 by Market Capitalization
Companies near Sinocare Inc in the global market cap rankings as of September 19, 2026. Review 300298 intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Sinocare Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $178.43 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.53 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $178.43 Billion | $102.61 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.13 |
| #238 | Stryker Corporation | NYSE:SYK | $105.53 Billion | $275.12 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Sinocare Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Sinocare Inc's market cap moved from $1.40 Billion to $ 1.28 Billion, with a yearly change of -0.25%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.28 Billion | -8.65% |
| 2025 | CN¥1.40 Billion | -33.71% |
| 2024 | CN¥2.12 Billion | -14.46% |
| 2023 | CN¥2.47 Billion | -9.27% |
| 2022 | CN¥2.73 Billion | +14.11% |
| 2021 | CN¥2.39 Billion | -15.89% |
| 2020 | CN¥2.84 Billion | +142.36% |
| 2019 | CN¥1.17 Billion | +44.46% |
| 2018 | CN¥811.39 Million | -35.17% |
| 2017 | CN¥1.25 Billion | +33.94% |
| 2016 | CN¥934.44 Million | -33.49% |
| 2015 | CN¥1.40 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Sinocare Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.28 Billion USD |
| MoneyControl | $1.28 Billion USD |
| MarketWatch | $1.28 Billion USD |
| marketcap.company | $1.28 Billion USD |
| Reuters | $1.28 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sinocare Inc
Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People's Republic of China. It offers blood glucose and pressure monitors; point of care testing products; digital management tool solutions; non-invasive screening products; and PTS and Trividia products. The company provides its products for the patients with chronic disease… Read more